Innova Unlimited

NMIBC Care in Latin America: Provider and Patient Perspectives

Challenges and opportunities in NMIBC management across Latin America: insights from healthcare providers and a patient advocacy group

Mark McCully¹, Julia Lipkis¹, Aryel Heller¹ and Adrian Huñis²

¹PharmaValue Partners, 603 Mattison Avenue, Suite 319, Asbury Park, NJ 07712, USA
²A. Hunis & Associates, Oncology Consultants, Hollywood, FL 33019, USA

Japón afirma haber descubierto un nuevo analgésico tan potente como la morfina, pero sin efectos secundarios

El nombre del compuesto es ADRIANA y en los ensayos clínicos ha mostrado una extraordinaria eficacia. Además, no genera dependencia, ya que sigue una ruta distinta

Discovery of a new analgesic promises pain relief with fewer downsides

Opioids like morphine are widely used in medical practice due to their powerful pain-relieving effects, yet they carry the risk of serious adverse effects such as respiratory depression and drug dependence. For this reason, Japan has strict regulations in place to ensure that these medications are prescribed only by authorized physicians.

Recent Advances in Small Cell Lung Cancer (SCLC) Over the Last Decade

Pioneering research conducted by Melisa Huñis MD and Adrián Huñis MD that integrates the latest advances in small cell lung cancer (SCLC): new immunotherapy treatments, molecular subtypes, imaging diagnostics, and future perspectives.